ExPLoRNA Therapeutics
With passion, ExploRNA Therapeutics develops ground-breaking innovations of mRNA as a therapeutic platform, applies those solutions in unique therapeutic programs, and delivers technology, therapeutic platform and therapies to pharmaceutical partners.
ExPLoRNA Therapeutics has raised €758k across 1 funding round from 1 investor, most recently a round in Dec 2022. Based in Warsaw, Poland; active in Healthtech. Data as of 28 Oct 2026.
Warsaw, Polandexplorna.com ↗
Total raised
€758k
€757,648
Funding rounds
1
Investors
1
distinct backers
Active since
2022-12
latest 2022-12
Funding by year
EUR raised per yearExPLoRNA Therapeutics — funding by year — interactive chart.
Data table
| ExPLoRNA Therapeutics — funding by year | |
|---|---|
| 2022 | €758k |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-12-09 | Other | €758k | Bill & Melinda Gates Foundation Trust | View deal → |
Investors
1Related news
Similar companies
same sector or country- InPost€2.8BPoland · Transportation
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Allegro€2.0BPoland · E-commerce
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
Global coverage: FundingData